NF-κB activation during intradermal DNA vaccination is essential for eliciting tumor protective antigen-specific CTL responses

References

• Tang DC, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992; 356:152 - 4; http://dx.doi.org/10.1038/356152a0; PMID: 1545867
   PubMed Web of Science ®Google Scholar
• Luxembourg A, Evans CF, Hannaman D. Electroporation-based DNA immunisation: translation to the clinic. Expert Opin Biol Ther 2007; 7:1647 - 64; http://dx.doi.org/10.1517/14712598.7.11.1647; PMID: 17961089
   PubMed Web of Science ®Google Scholar
• van Drunen Littel-van den Hurk S, Hannaman D. Electroporation for DNA immunization: clinical application. Expert Rev Vaccines 2010; 9:503 - 17; http://dx.doi.org/10.1586/erv.10.42; PMID: 20450325
   PubMed Web of Science ®Google Scholar
• Mlecnik B, Bindea G, Pagès F, Galon J. Tumor immunosurveillance in human cancers. Cancer Metastasis Rev 2011; 30:5 - 12; http://dx.doi.org/10.1007/s10555-011-9270-7; PMID: 21249426
   PubMed Web of Science ®Google Scholar
• Muul LM, Spiess PJ, Director EP, Rosenberg SA. Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J Immunol 1987; 138:989 - 95; PMID: 3100623
   PubMed Web of Science ®Google Scholar
• Igyártó BZ, Kaplan DH. Antigen presentation by Langerhans cells. Curr Opin Immunol 2013; 25:115 - 9; http://dx.doi.org/10.1016/j.coi.2012.11.007; PMID: 23246038
   PubMed Web of Science ®Google Scholar
• Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740 - 5; http://dx.doi.org/10.1038/35047123; PMID: 11130078
   PubMed Web of Science ®Google Scholar
• Kim T, Pazhoor S, Bao M, Zhang Z, Hanabuchi S, Facchinetti V, et al. Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc Natl Acad Sci U S A 2010; 107:15181 - 6; http://dx.doi.org/10.1073/pnas.1006539107; PMID: 20696886
   PubMed Web of Science ®Google Scholar
• Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007; 448:501 - 5; http://dx.doi.org/10.1038/nature06013; PMID: 17618271
   PubMed Web of Science ®Google Scholar
• Bürckstümmer T, Baumann C, Blüml S, Dixit E, Dürnberger G, Jahn H, et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 2009; 10:266 - 72; http://dx.doi.org/10.1038/ni.1702; PMID: 19158679
   PubMed Web of Science ®Google Scholar
• Kondo T, Kobayashi J, Saitoh T, Maruyama K, Ishii KJ, Barber GN, et al. DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking. Proc Natl Acad Sci U S A 2013; 110:2969 - 74; http://dx.doi.org/10.1073/pnas.1222694110; PMID: 23388631
   PubMed Web of Science ®Google Scholar
• Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010; 11:997 - 1004; http://dx.doi.org/10.1038/ni.1932; PMID: 20890285
   PubMed Web of Science ®Google Scholar
• Yang P, An H, Liu X, Wen M, Zheng Y, Rui Y, et al. The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat Immunol 2010; 11:487 - 94; http://dx.doi.org/10.1038/ni.1876; PMID: 20453844
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu YJ. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol 2011; 12:959 - 65; http://dx.doi.org/10.1038/ni.2091; PMID: 21892174
   PubMed Web of Science ®Google Scholar
• Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 2009; 10:1065 - 72; http://dx.doi.org/10.1038/ni.1779; PMID: 19609254
   PubMed Web of Science ®Google Scholar
• Roos AK, Eriksson F, Walters DC, Pisa P, King AD. Optimization of skin electroporation in mice to increase tolerability of DNA vaccine delivery to patients. Mol Ther 2009; 17:1637 - 42; http://dx.doi.org/10.1038/mt.2009.120; PMID: 19532140
   PubMed Web of Science ®Google Scholar
• Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 2005; 202:637 - 50; http://dx.doi.org/10.1084/jem.20050821; PMID: 16129706
   PubMed Web of Science ®Google Scholar
• Farkas A, Kemény L. Interferon-α in the generation of monocyte-derived dendritic cells: recent advances and implications for dermatology. Br J Dermatol 2011; 165:247 - 54; http://dx.doi.org/10.1111/j.1365-2133.2011.10301.x; PMID: 21410666
   PubMed Web of Science ®Google Scholar
• Shirota H, Petrenko L, Hattori T, Klinman DM. Contribution of IRF-3 mediated IFNbeta production to DNA vaccine dependent cellular immune responses. Vaccine 2009; 27:2144 - 9; http://dx.doi.org/10.1016/j.vaccine.2009.01.134; PMID: 19356618
   PubMed Web of Science ®Google Scholar
• Ishii KJ, Kawagoe T, Koyama S, Matsui K, Kumar H, Kawai T, et al. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 2008; 451:725 - 9; http://dx.doi.org/10.1038/nature06537; PMID: 18256672
   PubMed Web of Science ®Google Scholar
• Desmet CJ, Ishii KJ. Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat Rev Immunol 2012; 12:479 - 91; http://dx.doi.org/10.1038/nri3247; PMID: 22728526
   PubMed Web of Science ®Google Scholar
• Kopfnagel V, Wittmann M, Werfel T. Human keratinocytes express AIM2 and respond to dsDNA with IL-1β secretion. Exp Dermatol 2011; 20:1027 - 9; http://dx.doi.org/10.1111/j.1600-0625.2011.01382.x; PMID: 22092578
   PubMed Web of Science ®Google Scholar
• van Hogerlinden M, Rozell BL, Ahrlund-Richter L, Toftgård R. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res 1999; 59:3299 - 303; PMID: 10416581
   PubMed Web of Science ®Google Scholar
• Lladser A, Mougiakakos D, Tufvesson H, Ligtenberg MA, Quest AF, Kiessling R, et al. DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity. Mol Ther 2011; 19:594 - 601; http://dx.doi.org/10.1038/mt.2010.268; PMID: 21157438
   PubMed Web of Science ®Google Scholar
• Curtsinger JM, Valenzuela JO, Agarwal P, Lins D, Mescher MF, Type I. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J Immunol 2005; 174:4465 - 9; PMID: 15814665
   PubMed Web of Science ®Google Scholar
• Le Bon A, Etchart N, Rossmann C, Ashton M, Hou S, Gewert D, et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 2003; 4:1009 - 15; http://dx.doi.org/10.1038/ni978; PMID: 14502286
   PubMed Web of Science ®Google Scholar
• Leitner WW, Bergmann-Leitner ES, Hwang LN, Restifo NP, Type I. Type I Interferons are essential for the efficacy of replicase-based DNA vaccines. Vaccine 2006; 24:5110 - 8; http://dx.doi.org/10.1016/j.vaccine.2006.04.059; PMID: 16725231
   PubMed Web of Science ®Google Scholar
• Diebold SS, Schulz O, Alexopoulou L, Leitner WW, Flavell RA, Reis e Sousa C. Role of TLR3 in the immunogenicity of replicon plasmid-based vaccines. Gene Ther 2009; 16:359 - 66; http://dx.doi.org/10.1038/gt.2008.164; PMID: 19052633
   PubMed Web of Science ®Google Scholar
• Leitner WW, Hwang LN, deVeer MJ, Zhou A, Silverman RH, Williams BRG, et al. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med 2003; 9:33 - 9; http://dx.doi.org/10.1038/nm813; PMID: 12496961
   PubMed Web of Science ®Google Scholar
• Näslund TI, Kostic L, Nordström EK, Chen M, Liljeström P. Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines. Virol J 2011; 8:36; http://dx.doi.org/10.1186/1743-422X-8-36; PMID: 21261958
   PubMed Web of Science ®Google Scholar
• Amos SM, Pegram HJ, Westwood JA, John LB, Devaud C, Clarke CJ, et al. Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice. Cancer Immunol Immunother 2011; 60:671 - 83; http://dx.doi.org/10.1007/s00262-011-0984-8; PMID: 21327636
   PubMed Web of Science ®Google Scholar
• Xiao H, Peng Y, Hong Y, Huang L, Guo ZS, Bartlett DL, et al. Local administration of TLR ligands rescues the function of tumor-infiltrating CD8 T cells and enhances the antitumor effect of lentivector immunization. J Immunol 2013; 190:5866 - 73; http://dx.doi.org/10.4049/jimmunol.1203470; PMID: 23610140
   PubMed Web of Science ®Google Scholar
• Babiuk S, Mookherjee N, Pontarollo R, Griebel P, van Drunen Littel-van den Hurk S, Hecker R, et al. TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine. Immunology 2004; 113:114 - 20; http://dx.doi.org/10.1111/j.1365-2567.2004.01938.x; PMID: 15312142
   PubMed Web of Science ®Google Scholar
• Spies B, Hochrein H, Vabulas M, Huster K, Busch DH, Schmitz F, et al. Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice. J Immunol 2003; 171:5908 - 12; PMID: 14634101
   PubMed Web of Science ®Google Scholar
• Klinman DM, Yamshchikov G, Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 1997; 158:3635 - 9; PMID: 9103425
   PubMed Web of Science ®Google Scholar
• Coban C, Ishii KJ, Gursel M, Klinman DM, Kumar N. Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors. J Leukoc Biol 2005; 78:647 - 55; http://dx.doi.org/10.1189/jlb.1104627; PMID: 15961575
   PubMed Web of Science ®Google Scholar
• Ohlschläger P, Spies E, Alvarez G, Quetting M, Groettrup M. The combination of TLR-9 adjuvantation and electroporation-mediated delivery enhances in vivo antitumor responses after vaccination with HPV-16 E7 encoding DNA. Int J Cancer 2011; 128:473 - 81; http://dx.doi.org/10.1002/ijc.25344; PMID: 20309939
   PubMed Web of Science ®Google Scholar
• Mills KHG, Dunne A. Immune modulation: IL-1, master mediator or initiator of inflammation. Nat Med 2009; 15:1363 - 4; http://dx.doi.org/10.1038/nm1209-1363; PMID: 19966773
   PubMed Web of Science ®Google Scholar
• Roos AK, Eriksson F, Timmons JA, Gerhardt J, Nyman U, Gudmundsdotter L, et al. Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment. PLoS One 2009; 4:e7226; http://dx.doi.org/10.1371/journal.pone.0007226; PMID: 19789652
   PubMed Web of Science ®Google Scholar
• Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-κB signaling pathways. Nat Immunol 2011; 12:695 - 708; http://dx.doi.org/10.1038/ni.2065; PMID: 21772278
   PubMed Web of Science ®Google Scholar
• Prasad S, Ravindran J, Aggarwal BB. NF-kappaB and cancer: how intimate is this relationship. Mol Cell Biochem 2010; 336:25 - 37; http://dx.doi.org/10.1007/s11010-009-0267-2; PMID: 19823771
   PubMed Web of Science ®Google Scholar